Proposal to Authorize Reverse Stock Split has Been Approved ENGLEWOOD, Colo., Oct. 14, 2022 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and Chief Executive Officer, Mike…
Related Articles
Inovonics Introduces Fall Detection and Alarm Location Solutions
WESTMINSTER, Colo., Oct. 11, 2022 /PRNewswire/ — Inovonics, an industry leader in wireless solutions for life-safety applications, announces the launch of two new next-generation solutions for the senior living market: fall detection and alarm location. […]
One Enzyme Could be Behind Alcohol Addiction and Liver Disease
Scientists have uncovered a surprising connection between sugar metabolism and alcohol addiction, identifying a potential new therapeutic target for treating alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). Click here to view original post […]
Zynex, Inc. Reschedules Release of Fourth Quarter and Full Year 2022 Financial Results
ENGLEWOOD, Colo., March 10, 2023 /PRNewswire/ — Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced […]
